EFFECTS OF XANTHINE OXIDASE INHIBITORS ON PROGRESSION OF LEFT ANTERIOR DESCENDING ARTERY ATHEROMA BURDEN
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31782-0
Abstract: Xanthine Oxidoreductase (XOR) has been shown to be involved in the pathogenesis of atherosclerosis via its production of reactive oxygen species. There have been multiple animal studies showing that XOR and reactive oxygen species have… read more here.
Keywords: xanthine oxidase; progression left; left anterior; oxidase inhibitors ... See more keywords
Single institution experience looking at efficacy of PD-1 inhibitors after progression on PD-L1 inhibitors or vice-versa in metastatic non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e21726
Abstract: e21726Background: The treatment landscape for metastatic NSCLC has changed dramatically with emergence of checkpoint inhibitors (CPI). Even though all currently approved CPI target engagement of PD... read more here.
Keywords: looking efficacy; institution experience; efficacy inhibitors; inhibitors progression ... See more keywords